These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15071360)

  • 21. The Antiarrhythmic Action of the Na
    Kawakami S; Takada K; Aimoto M; Nagasawa Y; Kusakabe T; Kato K; Takahara A
    Biol Pharm Bull; 2023; 46(8):1120-1127. PubMed ID: 37532563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.
    Shiina H; Sugiyama A; Takahara A; Satoh Y; Hashimoto K
    Jpn Circ J; 2000 Oct; 64(10):777-82. PubMed ID: 11059619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs.
    Hagiwara-Nagasawa M; Kambayashi R; Goto A; Nunoi Y; Izumi-Nakaseko H; Takei Y; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2021 Mar; 21(3):206-215. PubMed ID: 33074476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of electropharmacological and proarrhythmic effects of donepezil using the halothane-anesthetized intact dogs and the conscious chronic atrioventricular block ones.
    Hagiwara-Nagasawa M; Kambayashi R; Goto A; Nunoi Y; Izumi-Nakaseko H; Chiba K; Wada T; Takei Y; Matsumoto A; Sugiyama A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):581-589. PubMed ID: 33064166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
    Chiba K; Sugiyama A; Satoh Y; Shiina H; Hashimoto K
    Toxicol Appl Pharmacol; 2000 Nov; 169(1):8-16. PubMed ID: 11076691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo.
    Matsukura S; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    Cardiovasc Toxicol; 2017 Apr; 17(2):157-162. PubMed ID: 27040813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and electrophysiologic effects of ontazolast in dogs.
    Hamlin RL; Nakayama T; Brady JT; Stoll RE
    Am J Vet Res; 2000 Nov; 61(11):1364-8. PubMed ID: 11108180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of magnesium sulfate on the canine cardiovascular system complicating astemizole overdose.
    Sugiyama A; Aye NN; Katahira S; Hagihara A; Hashimoto K
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):795-800. PubMed ID: 9234661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol.
    Sugiyama A; Satoh Y; Hashimoto K
    Toxicol Appl Pharmacol; 2001 Jun; 173(2):120-8. PubMed ID: 11384214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn Circ J; 2000 Jun; 64(6):445-51. PubMed ID: 10875735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amitriptyline May Have Possibility to Induce Brugada Syndrome Rather than Long QT Syndrome.
    Lubna NJ; Wada T; Nakamura Y; Chiba K; Cao X; Izumi-Nakaseko H; Ando K; Naito AT; Satoh Y; Sugiyama A
    Cardiovasc Toxicol; 2018 Feb; 18(1):91-98. PubMed ID: 28616803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a prostagrandin EP4-receptor agonist ONO-AE1-329 on the left ventricular pressure-volume relationship in the halothane-anesthetized dogs.
    Honda A; Nakamura Y; Ohara H; Cao X; Nomura H; Katagi J; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    Eur J Pharmacol; 2016 Mar; 775():130-7. PubMed ID: 26872985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs.
    Kondo Y; Hagiwara-Nagasawa M; Kambayashi R; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):419-426. PubMed ID: 32193875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.